ArticleFrontiers in immunology2026

Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies.

Lamia Al-Awuad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.